Percutaneous transluminal venous angioplasty in occlusive iliac vein thrombosis resistant to thrombolysis
Systemic thrombolysis is less than optimal in total occlusions of the iliac vein in which patency is 20% or less. We describe an interventional therapeutic procedure that may be effective in such cases. We selected 18 patients (average age, 29.5 years; range, 16 to 71 years) with complete iliac vein...
Gespeichert in:
Veröffentlicht in: | The American heart journal 1993-02, Vol.125 (2), p.362-366 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 366 |
---|---|
container_issue | 2 |
container_start_page | 362 |
container_title | The American heart journal |
container_volume | 125 |
creator | Marache, Philippe Asseman, Philippe Jabinet, Jean Louis Prat, Alain Bauchart, Jean Jacques Aisenfarb, Jean Charles Lesenne, Martine Jude, Brigitte Thery, Claude |
description | Systemic thrombolysis is less than optimal in total occlusions of the iliac vein in which patency is 20% or less. We describe an interventional therapeutic procedure that may be effective in such cases. We selected 18 patients (average age, 29.5 years; range, 16 to 71 years) with complete iliac vein occlusion that persisted after 24 to 48 hours of systemic thrombolysis (streptokinase 100,000 U/hr). The ipsilateral femoral vein was punctured, and a guide wire was gently advanced through the thrombus into the inferior vena cava. Multiple inflations were performed with a balloon catheter that was advanced on the wire. A temporary vena cava filter was placed as a protection against possible embolic migration. Systemic thrombolysis was administered for 24 to 48 hours. Control venography and pulmonary angiography were performed. Venography showed good recanalization in seven cases, incomplete recanalization in five cases, and failure in six cases. Patency was maintained for a long time (15.6 months). In conclusion, (1) percutaneous transluminal venous angioplasty is a valuable adjunct to systemic thrombolysis when the latter alone fails; (2) segmental flow and mechanical obstruction were the critical factors, since the pharmaceutical factors were held constant, and (3) a more aggressive incremental interventional strategy warrants consideration. |
doi_str_mv | 10.1016/0002-8703(93)90013-Y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75578975</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>000287039390013Y</els_id><sourcerecordid>75578975</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-d7ab5c66a0dea885994a9f130cadad24fbd9a9525d52caa6b27e02978e01d1ac3</originalsourceid><addsrcrecordid>eNp9kE9r3DAQxUVJSDd_vkELPoXk4FSSLcu6FEJImkCgPTSHnMRYmm1VZGsryQv77SOz2xwLQmLevHlifoR8YvSGUdZ9oZTyupe0uVLNtaKUNfXrB7JiVMm6k217RFbvlo_kNKU_pex4352Qk77lkvF-RdwPjGbOMGGYU5UjTMnPo5vAV1ucFg2mXy5sPKS8q9xUBWP8nNwWK-cdmOIqYv4dwziE5FIVsdwlL1c5_NP9rmjn5HgNPuHF4T0jLw_3P-8e6-fv357ubp9r0wiZaythEKbrgFqEvhdKtaDWrKEGLFjergerQAkurOAGoBu4RMqV7JEyy8A0Z-Ryn7uJ4e-MKevRJYPe73fUUgjZKymKsd0bTQwpRVzrTXQjxJ1mVC-E9YJPL_i0KmchrF_L2OdD_jyMaN-HDkhL_-u-j2XJrcOok3E4GbQuosnaBvf_D94AsYSOvQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75578975</pqid></control><display><type>article</type><title>Percutaneous transluminal venous angioplasty in occlusive iliac vein thrombosis resistant to thrombolysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Marache, Philippe ; Asseman, Philippe ; Jabinet, Jean Louis ; Prat, Alain ; Bauchart, Jean Jacques ; Aisenfarb, Jean Charles ; Lesenne, Martine ; Jude, Brigitte ; Thery, Claude</creator><creatorcontrib>Marache, Philippe ; Asseman, Philippe ; Jabinet, Jean Louis ; Prat, Alain ; Bauchart, Jean Jacques ; Aisenfarb, Jean Charles ; Lesenne, Martine ; Jude, Brigitte ; Thery, Claude</creatorcontrib><description>Systemic thrombolysis is less than optimal in total occlusions of the iliac vein in which patency is 20% or less. We describe an interventional therapeutic procedure that may be effective in such cases. We selected 18 patients (average age, 29.5 years; range, 16 to 71 years) with complete iliac vein occlusion that persisted after 24 to 48 hours of systemic thrombolysis (streptokinase 100,000 U/hr). The ipsilateral femoral vein was punctured, and a guide wire was gently advanced through the thrombus into the inferior vena cava. Multiple inflations were performed with a balloon catheter that was advanced on the wire. A temporary vena cava filter was placed as a protection against possible embolic migration. Systemic thrombolysis was administered for 24 to 48 hours. Control venography and pulmonary angiography were performed. Venography showed good recanalization in seven cases, incomplete recanalization in five cases, and failure in six cases. Patency was maintained for a long time (15.6 months). In conclusion, (1) percutaneous transluminal venous angioplasty is a valuable adjunct to systemic thrombolysis when the latter alone fails; (2) segmental flow and mechanical obstruction were the critical factors, since the pharmaceutical factors were held constant, and (3) a more aggressive incremental interventional strategy warrants consideration.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/0002-8703(93)90013-Y</identifier><identifier>PMID: 8427128</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Adolescent ; Adult ; Aged ; Angioplasty, Balloon - adverse effects ; Drug Resistance ; Female ; Follow-Up Studies ; Humans ; Iliac Vein - diagnostic imaging ; Male ; Middle Aged ; Phlebography ; Prospective Studies ; Streptokinase - therapeutic use ; Thrombolytic Therapy ; Thrombosis - drug therapy ; Thrombosis - therapy ; Treatment Outcome</subject><ispartof>The American heart journal, 1993-02, Vol.125 (2), p.362-366</ispartof><rights>1993</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-d7ab5c66a0dea885994a9f130cadad24fbd9a9525d52caa6b27e02978e01d1ac3</citedby><cites>FETCH-LOGICAL-c357t-d7ab5c66a0dea885994a9f130cadad24fbd9a9525d52caa6b27e02978e01d1ac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0002-8703(93)90013-Y$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8427128$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marache, Philippe</creatorcontrib><creatorcontrib>Asseman, Philippe</creatorcontrib><creatorcontrib>Jabinet, Jean Louis</creatorcontrib><creatorcontrib>Prat, Alain</creatorcontrib><creatorcontrib>Bauchart, Jean Jacques</creatorcontrib><creatorcontrib>Aisenfarb, Jean Charles</creatorcontrib><creatorcontrib>Lesenne, Martine</creatorcontrib><creatorcontrib>Jude, Brigitte</creatorcontrib><creatorcontrib>Thery, Claude</creatorcontrib><title>Percutaneous transluminal venous angioplasty in occlusive iliac vein thrombosis resistant to thrombolysis</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Systemic thrombolysis is less than optimal in total occlusions of the iliac vein in which patency is 20% or less. We describe an interventional therapeutic procedure that may be effective in such cases. We selected 18 patients (average age, 29.5 years; range, 16 to 71 years) with complete iliac vein occlusion that persisted after 24 to 48 hours of systemic thrombolysis (streptokinase 100,000 U/hr). The ipsilateral femoral vein was punctured, and a guide wire was gently advanced through the thrombus into the inferior vena cava. Multiple inflations were performed with a balloon catheter that was advanced on the wire. A temporary vena cava filter was placed as a protection against possible embolic migration. Systemic thrombolysis was administered for 24 to 48 hours. Control venography and pulmonary angiography were performed. Venography showed good recanalization in seven cases, incomplete recanalization in five cases, and failure in six cases. Patency was maintained for a long time (15.6 months). In conclusion, (1) percutaneous transluminal venous angioplasty is a valuable adjunct to systemic thrombolysis when the latter alone fails; (2) segmental flow and mechanical obstruction were the critical factors, since the pharmaceutical factors were held constant, and (3) a more aggressive incremental interventional strategy warrants consideration.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Angioplasty, Balloon - adverse effects</subject><subject>Drug Resistance</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Iliac Vein - diagnostic imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Phlebography</subject><subject>Prospective Studies</subject><subject>Streptokinase - therapeutic use</subject><subject>Thrombolytic Therapy</subject><subject>Thrombosis - drug therapy</subject><subject>Thrombosis - therapy</subject><subject>Treatment Outcome</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9r3DAQxUVJSDd_vkELPoXk4FSSLcu6FEJImkCgPTSHnMRYmm1VZGsryQv77SOz2xwLQmLevHlifoR8YvSGUdZ9oZTyupe0uVLNtaKUNfXrB7JiVMm6k217RFbvlo_kNKU_pex4352Qk77lkvF-RdwPjGbOMGGYU5UjTMnPo5vAV1ucFg2mXy5sPKS8q9xUBWP8nNwWK-cdmOIqYv4dwziE5FIVsdwlL1c5_NP9rmjn5HgNPuHF4T0jLw_3P-8e6-fv357ubp9r0wiZaythEKbrgFqEvhdKtaDWrKEGLFjergerQAkurOAGoBu4RMqV7JEyy8A0Z-Ryn7uJ4e-MKevRJYPe73fUUgjZKymKsd0bTQwpRVzrTXQjxJ1mVC-E9YJPL_i0KmchrF_L2OdD_jyMaN-HDkhL_-u-j2XJrcOok3E4GbQuosnaBvf_D94AsYSOvQ</recordid><startdate>19930201</startdate><enddate>19930201</enddate><creator>Marache, Philippe</creator><creator>Asseman, Philippe</creator><creator>Jabinet, Jean Louis</creator><creator>Prat, Alain</creator><creator>Bauchart, Jean Jacques</creator><creator>Aisenfarb, Jean Charles</creator><creator>Lesenne, Martine</creator><creator>Jude, Brigitte</creator><creator>Thery, Claude</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19930201</creationdate><title>Percutaneous transluminal venous angioplasty in occlusive iliac vein thrombosis resistant to thrombolysis</title><author>Marache, Philippe ; Asseman, Philippe ; Jabinet, Jean Louis ; Prat, Alain ; Bauchart, Jean Jacques ; Aisenfarb, Jean Charles ; Lesenne, Martine ; Jude, Brigitte ; Thery, Claude</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-d7ab5c66a0dea885994a9f130cadad24fbd9a9525d52caa6b27e02978e01d1ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Angioplasty, Balloon - adverse effects</topic><topic>Drug Resistance</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Iliac Vein - diagnostic imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Phlebography</topic><topic>Prospective Studies</topic><topic>Streptokinase - therapeutic use</topic><topic>Thrombolytic Therapy</topic><topic>Thrombosis - drug therapy</topic><topic>Thrombosis - therapy</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marache, Philippe</creatorcontrib><creatorcontrib>Asseman, Philippe</creatorcontrib><creatorcontrib>Jabinet, Jean Louis</creatorcontrib><creatorcontrib>Prat, Alain</creatorcontrib><creatorcontrib>Bauchart, Jean Jacques</creatorcontrib><creatorcontrib>Aisenfarb, Jean Charles</creatorcontrib><creatorcontrib>Lesenne, Martine</creatorcontrib><creatorcontrib>Jude, Brigitte</creatorcontrib><creatorcontrib>Thery, Claude</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marache, Philippe</au><au>Asseman, Philippe</au><au>Jabinet, Jean Louis</au><au>Prat, Alain</au><au>Bauchart, Jean Jacques</au><au>Aisenfarb, Jean Charles</au><au>Lesenne, Martine</au><au>Jude, Brigitte</au><au>Thery, Claude</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Percutaneous transluminal venous angioplasty in occlusive iliac vein thrombosis resistant to thrombolysis</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>1993-02-01</date><risdate>1993</risdate><volume>125</volume><issue>2</issue><spage>362</spage><epage>366</epage><pages>362-366</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><abstract>Systemic thrombolysis is less than optimal in total occlusions of the iliac vein in which patency is 20% or less. We describe an interventional therapeutic procedure that may be effective in such cases. We selected 18 patients (average age, 29.5 years; range, 16 to 71 years) with complete iliac vein occlusion that persisted after 24 to 48 hours of systemic thrombolysis (streptokinase 100,000 U/hr). The ipsilateral femoral vein was punctured, and a guide wire was gently advanced through the thrombus into the inferior vena cava. Multiple inflations were performed with a balloon catheter that was advanced on the wire. A temporary vena cava filter was placed as a protection against possible embolic migration. Systemic thrombolysis was administered for 24 to 48 hours. Control venography and pulmonary angiography were performed. Venography showed good recanalization in seven cases, incomplete recanalization in five cases, and failure in six cases. Patency was maintained for a long time (15.6 months). In conclusion, (1) percutaneous transluminal venous angioplasty is a valuable adjunct to systemic thrombolysis when the latter alone fails; (2) segmental flow and mechanical obstruction were the critical factors, since the pharmaceutical factors were held constant, and (3) a more aggressive incremental interventional strategy warrants consideration.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>8427128</pmid><doi>10.1016/0002-8703(93)90013-Y</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-8703 |
ispartof | The American heart journal, 1993-02, Vol.125 (2), p.362-366 |
issn | 0002-8703 1097-6744 |
language | eng |
recordid | cdi_proquest_miscellaneous_75578975 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adolescent Adult Aged Angioplasty, Balloon - adverse effects Drug Resistance Female Follow-Up Studies Humans Iliac Vein - diagnostic imaging Male Middle Aged Phlebography Prospective Studies Streptokinase - therapeutic use Thrombolytic Therapy Thrombosis - drug therapy Thrombosis - therapy Treatment Outcome |
title | Percutaneous transluminal venous angioplasty in occlusive iliac vein thrombosis resistant to thrombolysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T07%3A19%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Percutaneous%20transluminal%20venous%20angioplasty%20in%20occlusive%20iliac%20vein%20thrombosis%20resistant%20to%20thrombolysis&rft.jtitle=The%20American%20heart%20journal&rft.au=Marache,%20Philippe&rft.date=1993-02-01&rft.volume=125&rft.issue=2&rft.spage=362&rft.epage=366&rft.pages=362-366&rft.issn=0002-8703&rft.eissn=1097-6744&rft_id=info:doi/10.1016/0002-8703(93)90013-Y&rft_dat=%3Cproquest_cross%3E75578975%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75578975&rft_id=info:pmid/8427128&rft_els_id=000287039390013Y&rfr_iscdi=true |